NOORULT

Guardian Pharmacy Services, Inc.GRDN

NYSEConsumer EssentialsRetail-Drug Stores and Proprietary Stores
Price (close)
$41.79
Market cap
—
P/E
—
Revenue (TTM)
$1.5B
Net income
$65.9M
Dividend yield
—
1-year total return
64.2%
Net margin
4.5%
Revenue growth
10.3%
Debt / equity
0.00x

What Guardian Pharmacy Services, Inc. does.

We are a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. We emphasize high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as assisted living facilities (“ALFs”), and behavioral health facilities and group homes (collectively “BHFs”). More than two-thirds of our annual revenue for each of the past three years has been generated from residents of ALFs and BHFs, which are our target markets, while the remainder has been generated primarily from residents of skilled nursing facilities (“SNFs”). Additionally, our robust suite of capabilities enables us to serve residents in all types of LTCFs. We are a trusted partner to residents, LTCFs and health plan payors because we help reduce errors in drug administration, manage and ensure adherence to drug regimens, and lower overall healthcare costs. As of December 31, 2025, our 61 pharmacies, 54 of which are full-service, served approximately 205,000 residents in approximately 8,400 LTCFs across 38 states.

Revenue and profit, by fiscal year.

Fiscal year2022202320242025
Revenue——$1.2B$1.4B
Net income——-$110.0M$49.2M
Free cash flow——$43.3M$86.8M

More on GRDN.

Figures from Guardian Pharmacy Services, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.